arrow
K

Keiichi Hatakeyama

shizuoka cancer center research institute
H指数:22
被引数:1,940

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Des-Gamma-Carboxy Prothrombin Is Associated With Tumor Aggressiveness and Recurrence in Resected Early-Stage Hepatocellular Carcinoma: A Clinicopathological and Molecular Analysis

γ-羧基缺失凝血酶原与切除术后早期肝癌的肿瘤侵袭性和复发相关:一项临床病理和分子分析

2026-09-080
PRE
Translating spatial transcriptomic signatures in adenosquamous carcinoma into bulk prognostic biomarkers in lung adenocarcinoma: a bottom-up approach

将腺鳞癌的空间转录组特征转化为肺腺癌的大量预后生物标志物: 自下而上的方法

2026-01-230
OAAI
Novel CYP2A7/CYP2A6 germline hybrids associated with mutation burden in lung cancer revealed by whole-genome long-read sequencing

由全基因组长读测序揭示的新型CYP2A7/CYP2A6种系嵌合体与肺癌突变负荷的关联

2025-11-210
OAAI
Classification based on tumor phenotypes enables the novel molecular characterization of esophagogastric junction cancer

基于肿瘤表型的分类能够实现食管胃结合部癌的新型分子特征描述

2025-09-260
PRE
Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome

评估全基因组测序在识别癌症基因组驱动改变中的效用

2024-10-120
OAAI
Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes
2022-10-261
OAAI
BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer

BMP4和PHLDA1是KRAS G12A-,G12D-和G12V-driven结直肠癌的合理药物靶向候选基因

2021-05-125
OAAI